Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17495206 | 1.00 | LMNA (0.30) | LMNA | |
| SCHEMBL2467972 | 0.81 | — | — | |
| SCHEMBL333486 | 0.81 | — | — | |
| SCHEMBL333487 | 0.81 | — | — | |
| SCHEMBL247396 | 0.74 | LMNA (0.35) | LMNA | |
| SCHEMBL247397 | 0.74 | LMNA (0.35) | LMNA | |
| SCHEMBL28152596 | 0.74 | — | — | |
| SCHEMBL31681660 | 0.73 | — | — | |
| SCHEMBL1221778 | 0.73 | LMNA (0.32) | LMNA | |
| SCHEMBL31688160 | 0.73 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9790150-B2 | Processes for producing branched fluoroalkyl olefins | THE CHEMOURS COMPANY FC, LLC (US) | 2017-10-17 | — | — | US | disclosed |
| WO-2016025179-A1 | PROCESSES FOR PRODUCING BRANCHED FLUOROALKYL OLEFINS | THE CHEMOURS COMPANY FC, LLC (US) | 2016-02-18 | — | — | WO | disclosed |
| US-20160046547-A1 | PROCESSES FOR PRODUCING BRANCHED FLUOROALKYL OLEFINS | JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT | 2016-02-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160046547-A1 | PROCESSES FOR PRODUCING BRANCHED FLUOROALKYL OLEFINS | BBOX1, CYP8B1, TALDO1 | LMNA 4423/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.